MNPR
Monopar Therapeutics·NASDAQ
--
--(--)
--
--(--)
MNPR fundamentals
Monopar Therapeutics (MNPR) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.35 (YoY +30.00%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.35
+30.00%
Report date
Aug 12, 2025
Earnings Call
8:15 AM on Aug 12, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Monopar Therapeutics (MNPR) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Monopar Therapeutics (MNPR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Monopar Therapeutics (MNPR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Monopar Therapeutics (MNPR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Monopar Therapeutics (MNPR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Monopar Therapeutics (MNPR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Monopar Therapeutics's latest dividend and current dividend yield?What does Monopar Therapeutics do and what are its main business segments?What guidance did Monopar Therapeutics's management provide for the next earnings period?What factors drove the changes in Monopar Therapeutics's revenue and profit?What were the key takeaways from Monopar Therapeutics’s earnings call?What is the market's earnings forecast for Monopar Therapeutics next quarter?Did Monopar Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Monopar Therapeutics's earnings call?
